Simcere Pharmaceutical Group
Simcere is a leading Chinese pharmaceutical company specializedin developing,manufacturing and marketing of innovative medicines and branded generics. The Companyhas had strong topline growth of over 30% for the past three years, and possesses astrong development team and distribution network, all managedby industry veterans.
Simcereactively seeks outpartnershipopportunities for both R&D projects and launched products in the areas ofoncology, neurology, rheumatology and immunology, as well as for infectious, cardiovascular, and metabolic diseases.Current partners include BMS, Daiichi Sankyo, GSK and Apexigen, etc.The Company has also participated in 8 prestigious venture capitals and invested over$150millioninto innovative healthcare projects worldwide.